CLINICAL RESEARCH · AFFRON®
Affron® Before Bed: A 120-Participant Clinical Trial*
A 28-day randomized, double-blind, placebo-controlled study investigated 14 mg and 28 mg doses of affron® taken one hour before bedtime in 120 adults with unsatisfactory sleep.
*Lopresti AL, Smith SJ, Drummond PD. An investigation into an evening intake of a saffron extract (affron®) on sleep quality, cortisol, and melatonin concentrations in adults with poor sleep: a randomised, double-blind, placebo-controlled, multi-dose study. Sleep Med. 2021;86:7–18. doi:10.1016/j.sleep.2021.08.001.
• Affron® was associated with greater improvements in sleep-quality ratings compared with placebo. †
• Improvements were also observed in insomnia-related outcomes and mood after awakening. †
• Evening melatonin concentrations increased compared with placebo. †
• Improvements were similar between the 14 mg and 28 mg doses. †